产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
雌二醇(称为 α-雌甾二醇或 17α-雌二醇)为人类乳腺癌细胞组织培养中的生物活性雌激素。17-雌二醇及其选择性受体 (ER-X) 不是传统激素/受体内分泌系统的一部分，而是在成人大脑生长中具有重要自分泌/旁分泌功能的系统的一部分。在更年期以及神经退化性疾病(例如阿尔茨海默氏病和缺血性中风)的治疗中，17-雌二醇可能对激素替代物疗法具有重要意义。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAC3407 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C18H24O2 |
| 分子量 | 272.38 |
| MDL编号 | MFCD00064144 |
产品性质
| 等级 | certified reference material pharmaceutical secondary standard |
| 形式 | powder |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 50 mg |
| 储存温度 | 2-30℃ |
| SMILES string | [H][C@]12CC[C@]3(C)[C@H](O)CC[C@@]3([H])[C@]1([H])CCc4cc(O)ccc24 |
| InChI | 1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17-,18+/m1/s1 |
| InChI key | VOXZDWNPVJITMN-SFFUCWETSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Danger |
| 危险声明 | H341 - H351 - H360F - H362 - H410 |
| 预防措施声明 | P202 - P260 - P263 - P264 - P273 - P308 + P313 |
| 危险分类 | Aquatic Chronic 1 - Carc. 2 - Lact. - Muta. 2 - Repr. 1A |
| 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
